Jext (adrenaline (epinephrine) acid tartrate) Adrenaline Auto-Injector Now PBS Listed and Available in Australia
- eherz0
- 3 days ago
- 1 min read
Biocelect Pty Ltd today announced the Australian launch of Jext, a new adrenaline autoinjector now listed on the Pharmaceutical Benefits Scheme (PBS) and available nationally, supporting subsidised access for eligible patients for the emergency treatment of anaphylaxis (1-2).
The introduction of Jext adds an additional PBS listed adrenaline autoinjector option to the established anaphylaxis treatment landscape in Australia, providing healthcare professionals and pharmacists with greater choice when supporting patients at risk of severe allergic reactions.
Jext is a pre-filled autoinjector designed for easy use and is available in two strengths (150 micrograms and 300 micrograms) to support weight-based prescribing (1).
See more in the full media release document below
References:
1. Jext® 300 & Jext® Jnr 150 (adrenaline (epinephrine) acid tartrate) Australian Product Information. 2026